Wedgewood Partners Reports Fourth Quarter 2025 Results and Outlook
Wedgewood Partners released its Q4 2025 investor letter, reporting a -1.8% net return and citing stock selection issues and AI underweighting. The letter highlighted Edwards Lifesciences as a positive contributor.